Baird Financial Group’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5,801	Closed	-$225K	–	1797
2022 Q1	$225K	Buy	5,801 +1,892	+48%	+$73.4K	﹤0.01%	1716
2021 Q4	$229K	Hold	3,909	–	–	﹤0.01%	1778
2021 Q3	$232K	Buy	+3,909	New	+$232K	﹤0.01%	1759